Food Partner Network News, the U.S. Food and Drug Administration recently announced that it will be using open-air Atlantic salmon for AquAdvantage's genetically modified technology from September 19 to 21, 2010 for two open discussions.
It was announced that at this meeting, the U.S. Food and Drug Administration Veterinary Advisory Committee will study the scientific issues that AquaBounty Technologies has applied for approval of AquAdvantage salmon.
The first day of public discussion of the veterinary advisory committee members will assess the technical direction of these animal transgenic animals and the FDA's regulatory process. The next day, the FDA report involved animal health, food safety, and environmental issues. According to the data: AquAdvantage salmon reproduces faster than conventionally reared Atlantic salmon.
On the third day of the meeting, the US Food and Drug Administration plans to hold an open discussion: the current legal principles related to food labeling, and explain the information provided prior to the hearing about the genetically modified fish. The US FDA stated: "This is the FDA's responsibility to begin with AquAdvantage eel, the application of food, according to federal law, and a hearing to determine if there is a special label that gives citizens the opportunity to comment on the label."
On Friday, the Consumer Animal Welfare Coalition, the Commercial and Recreational Fisheries Association, and food retailers, as well as environmental groups, submitted a joint statement criticizing the US Food and Drug Administration for announcing the approval of the genetically modified AquAdvantage carp for human consumption.
“We all know that squid is in great demand, but the solution is not to satisfy our table with the 'farm' genetic engineering version. The solution is to get the wild squid population back through our work.†Chairman of the Salmon AID Foundation, Conservation Biology Rosenfeld Jonathan, PhD, said: "Approving these genetically modified fish only exacerbates the wild fish problems we face."
AquaBounty first submitted Atlantic salmon using genetically modified technology in 1999. According to the January 2007 FDA document entitled "The Future of Genetically Modified Food Animals," Aq Advantage of Atlantic Salmon, "the promoter containing the Chinook salmon growth hormone gene promotes rapid reproduction at low temperatures."
In 2007, AquaBounty also began to develop fin fish to shorten the ripening period by nearly half. According to FDA documents, AquAdvantage anticipates that its genetically modified fish was approved by the US FDA in 2006. The company plans to launch a commercial business in 2009.
After the document was published, scientists expressed concern that sexual reproduction of genetically modified fish (food companions: there is no precedent for the introduction of bred genetically modified animals into nature) will release into nature will extinction of natural fish populations.
Marian. Carfen said, "We believe that the approval of any genetically modified carp will pose a serious threat to the survival of the indigenous carp population, many of which have been severely affected by the related carp farms and other human-induced effects."
The North West Atlantic Coast Alliance and science and policy coordinator at the North Atlantic Salmon Conservation Organization, Boyce Thorne Miller, added: “If GM salmon are considered a serious threat to wild salmon, FDA approval of genetically modified squid will be a serious violation. The United States has signed an agreement for conservation of carp."
Shangqiu Jinda Tools Co.,Ltd , https://www.jindameasuring.com